2015 - 2020

Makar K, Sasaki K. Roadmap of germline development and in vitro gametogenesis from pluripotent stem cells. Andrology 2019, doi: 10.1111/andr.12726.

Yamashiro, C., Sasaki, K., Yabuta, Y., Kojima, Y., Nakamura, T., Okamoto, I., Yokobayashi, S., Murase, Y., Ishikura, Y., Shirane, K., Sasaki, H., Yamamoto, T., Saitou, M. Generation of human oogonia from induced pluripotent stem cells in vitro. Science 2018, 362(6412):356-360

Miyauchi H, Ohta H, Nagaoka S, Nakaki F, Sasaki K, Hayashi K, Yabuta Y, Nakamura T, Yamamoto T, Saitou M. Bone morphogenetic protein and retinoic acid synergistically specify female germ-cell fate in mice. EMBO J. 2017, 36(21):3100-3119

Kojima Y, Sasaki K, Yokobayashi S, Sakai Y, Nakamura T, Yabuta Y, Nakaki F, Nagaoka S, Woltjen K, Hotta A, Yamamoto T, Saitou M. Evolutionarily Distinctive Transcriptional and Signaling Programs Drive Human Germ Cell Lineage Specification from Pluripotent Stem Cells. Cell Stem Cell. 2017, 21(4):517-532

Nakamura T, Yabuta Y, Okamoto I, Sasaki K, Iwatani C, Tsuchiya H, Saitou M. Single-cell transcriptome of early embryos and cultured embryonic stem cells of cynomolgus monkeys. Sci Data. 2017, 4:170067

Sasaki K, Nakamura T, Okamoto I, Yabuta Y, Iwatani C, Tsuchiya H, Shiraki N, Takakuwa T, Yamamoto T, Seita Y, Nakamura S, Saitou M. The germ cell fate of cynomolgus monkeys is specified in the nascent amnion. Dev. Cell. 2016, 39(2):169-185.

Nakamura T, Okamoto I, Sasaki K, Yabuta Y, Iwatani C, Tsuchiya H, Seita Y, Nakamura S, Yamamoto T, Saitou M. A developmental coordinate of pluripotency among mice, monkeys and humans. Nature. 2016, 537(7618):57-62.

Sasaki K, Yokobayashi S, Nakamura T, Okamoto I, Yabuta Y, Kurimoto K, Ohta H, Moritoki Y, Iwatani C, Tsuchiya H, Nakamura S, Sekiguchi K, Sakuma T, Yamamoto T, Mori T, Woltjen K, Nakagawa M, Yamamoto T, Takahashi K, Yamanaka S, Saitou M. Robust in vitro induction of human germ cell fate from pluripotent stem cells. Cell Stem Cell. 2015, 17(2):178-194.

Dai D*, Sasaki K*, Lin MY, Smith KD, Nicosia RF, Alpers CE, Najafian B. Interstitial eosinophilic aggregates in diabetic nephropathy: allergy or not? Nephrol Dial Transplant. 2015, 30(8):1370-1376. *equal contribution

Sis B, Bagnasco SM, Cornell LD, Randhawa P, Haas M, Lategan B, Magil AB, Herzenberg AM, Gibson IW, Kuperman M, Sasaki K, Kraus ES. Isolated endarteritis and kidney transplant survival: A multicenter collaborative study. J Am Soc Nephrol. 2015, 26(5):1216-1227.


2010 - 2014

Sasaki K, Anderson E, Shankland SJ, Nicosia RF. Diffuse proliferative glomerulonephritis associated with Cetuximab, an epidermal growth factor receptor inhibitor. Am J Kidney Dis. 2013, 61(6): 988-991.

Sasaki K, Chang A, Najafian B. Indolent systemic mastocytosis associated with light chain deposition disease. Clin Kidney J. 2012, 5(5): 424-427.

Sasaki K, Kumar A, Chenal ME, Nicosia RF. Intraglomerular micrometastasis of squamous cell carcinoma. Clin Kidney J. 2012, 5(4):292-296.

Sasaki K, Bastacky SI, Hrebinko RL, Parwani AV, Zynger DL. Glomus tumor of the kidney: Case report and literature review. Int J Surg Pathol. 2011, 19(3):393-397.

Sasaki K, Parwani AV, Demetris AJ, Sasatomi E. Heterotopic breast epithelial inclusion of the heart: report of a case. Am J Surg Pathol. 2010; 34(10):1555-1559.

Sasaki K, Desimone M, Rao HR, Huang GJ, Seethala RR. Adrenocortical carcinosarcoma: a case report and review of the literature. Diagn Pathol. 2010, 5;5:51.

Sasaki K, Kohanbash G, Hoji A, Ueda R, McDonald HA, Reinhart TA, Martinson J, Lotze MT, Marincola FM, Wang E, Fujita M and Okada H. MiR-17-92 expression in differentiated T cells - implications for cancer immunotherapy. J Transl Med. 2010, 18; 8:17.


2000 - 2009

Sasaki K, Bastacky SI, Zynger DL, Parwani AV. Use of immunohistochemical markers to confirm the presence of vas deferens in vasectomy specimen. Am J Clin Pathol. 2009, 132 (6):893-898.

Ueda R, Fujita M, Zhu X, Sasaki K, Kastenhuber ER, Kohanbash G, McDonald HA, Harper J, Lonning S, Okada H. Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-asociated antigen peptide vaccine. Clin Cancer Res. 2009, 15(21):6551-6559.

Sasaki KPardee AD, Qu Y, Zhao X, Ueda R, Kohanbash G, Bailey, LM, Okada H, Muthuswamy R, Kalinski P, Basse PH, Falo LD, Storkus WJ. IL-4 suppresses Very Late Antigen-4 expression which is required for therapeutic Th1 T cell trafficking into tumors. J Immunother. 2009, 32(8):793-802.

Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber E, McDonald HA, Potter DM, Lotze MT, Khan S, Sobol R, Okada H. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulating ICAM-1 expression. Proc Natl Acad Sci USA. 2009, 106(26):10746-10751.

Fujita M, Zhu X, Ueda R, Sasaki K, Kohanbash G, Kastenhuber ER, McDonald HA, Gibson GA, Watkins SC, Muthuswamy R, Kalinski P, Okada H. Effective immunotherapy against murine glioma using type 1 polarizing dendritic cells-Significant roles of CXCL10. Cancer Res. 2009, 69(4):1587-1595.

Sasaki K, Pardee AD, Okada H, Storkus WJ. IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit. Eur J Immunol. 2008, 38(10):2865-2873.

Sasaki K, Zhao Z, Pardee AD, Ueda R, Fujita M, Sehra S, Kaplan MH, Kane LP, Okada H, Storkus WJ. Stat6 signaling suppresses VLA-4 expression by CD8+ T cells limits their ability to infiltrate tumor lesions in vivo. J Immunol. 2008, 181(1):104-108.

Fujita M, Zhu X, Sasaki K, Ueda R, Low KL, Pollack IF, Okada H. Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma. J Immunol. 2008, 180(4):2089-2098.

Ueda R, low KL, Zhu X, Fujita M, Sasaki K, Whiteside TL, Butterfield LH, Okada H. Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma. J Transl Med. 2007, 5(1):68.

Nakamura Y, Watchmaker P, Urban J, Sheridan B, Giermasz A, Nishimura F, Sasaki K, Cumberland R, Muthuswamy R, Mailliard RB, Larregina AT, Falo LD, Gooding W, Storkus WJ, Okada H, Hendricks RL, Kalinski P. Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity. Cancer Res. 2007, 67 (20): 10012-10018.

Sasaki K, Zhu X, Vasquez C, Nishimura F, Dusak JE, Huang J, Fujita M, Wesa A, Potter DM, Walker PR, Storkus WJ, Okada H. Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors. Cancer Res. 2007, 67(13):6451-6458.

Zhu X, Nishimura F, Sasaki K, Fujita M, Dusak JE, Eguchi J, Fellows-Mayle W, Storkus WJ, Walker PR, Salazar AM, Okada H. Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med. 2007, 5:10.

Sasaki K, Tsuji T, Jinushi T, Matsuzaki J, Sato T, Chamoto K, Togashi Y, Koda T, Nishimura T. Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets. Int Immunol. 2003, 15(6):701-710.


Book Chapter

Sasaki K. Artificial Oocyte and Artificial Ovary Development. In: Bukulmez O. (eds) Diminished Ovarian Reserve and Assisted Reproductive Technologies. 2020 Springer, Cham